Industry News
Epigenetic Therapy Shows Promise In Hard-to-treat Lung Cancer
Nov 10, 2011
Patients with recurrent metastatic non-small cell lung cancer have a morbid prognosis, but a new epigenetic therapy may have potential for this population, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research... Read More
New Anti-Malaria Route Raises Vaccine Hope
Nov 10, 2011
Using a technique devised at the Wellcome Trust Sanger Institute, researchers found that the malaria parasite uses a unique receptor to gain entry and infect human red blood cells. They hope their discovery, which they describe in a study published online in Nature this week, opens a promising new route to the successful development of an anti-malaria vaccine... Read More
Screening For Broad Range Of Cancer-Causing Genetic Changes Can Be Implemented Into Routine Clinical Practice
Nov 10, 2011
Researchers in the United States have shown, for the first time, that it is possible to screen cancer patients for a broad range of cancer-causing genetic mutations as part of normal clinical practice. By identifying patients' individual genotypes within a relatively short time frame, doctors are able to target tumours with the most appropriate therapy... Read More
Viagra Combats Malignant Melanoma
Nov 10, 2011
At first it sounds like good news: The body's own immune system gets active in almost every cancer - however, not necessarily for the benefit of the patient. "We distinguish between two different types of immune response," says Professor Dr. Viktor Umansky, immunologist at DKFZ and University Medical Center Mannheim. "On the one hand, cells of the immune system specifically attack tumor cells... Read More
Burkitt's Lymphoma Generally Rare But Common In Children In Equatorial Africa
Nov 10, 2011
Although Burkitt's lymphoma is thankfully fairly rare in the general population, it is the most common form of malignancy in children in Equatorial Africa and is very frequent in immunocompromised persons, such as those suffering from AIDS. It is invariably accompanied by an increase in the expression of a particular gene, the so-called c-myc gene... Read More
Vaccine For Metastatic Breast, Ovarian Cancer Shows Promise
Nov 09, 2011
Treatment with a recombinant poxviral vaccine showed a positive response in both metastatic breast cancer and ovarian cancer, according to a trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "With this vaccine, we can clearly generate immune responses that lead to clinical responses in some patients," said lead researcher James Gulley, M.D... Read More
Thomas Jefferson University Hospital First Academic Medical Center To Offer FDA-Approved BRAF Mutation Test For Melanoma Patients
Nov 09, 2011
Thomas Jefferson University Hospital is the first academic medical center in the United States to offer the recently-approved U.S. Food and Drug Administration (FDA) diagnostic tool that tests melanoma patients for the BRAF mutation (which occurs in about half of all cases) and ultimately determines if they'll benefit from a new, potentially life-saving drug... Read More
"If Hamlet Give The First Or Second Hit", The Development Of Burkitt's Lymphoma
Nov 09, 2011
Although Burkitt's lymphoma is thankfully fairly rare in the general population, it is the most common form of malignancy in children in Equatorial Africa and is very frequent in immunocompromised persons, such as those suffering from AIDS. It is invariably accompanied by an increase in the expression of a particular gene, the so-called c-myc gene... Read More
Teaching Hospitals Best For Prostate Cancer Surgery
Nov 09, 2011
Prostate cancer patients who undergo radical prostatectomy get better results at teaching hospitals than at non-academic medical institutions, according to the findings of an international study led by researchers at Henry Ford Hospital... Read More
Metastatic Breast And Ovarian Cancer Vaccine - Promising Results
Nov 08, 2011
A trial published in Clinical Cancer Research demonstrated a positive response in both metastatic breast cancer and ovarian cancer to a recombinant poxviral vaccine. Lead investigator James Gulley, M.D., Ph.D... Read More
Previous Page Next Page